Invitae Corporation
NVTA
Clasificación en acciones
#35794
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Precio por acción
$0.016
Última sincronización: 2024-03-11
Capitalización bursátil
$3.27M
Cambio (1 día)
-5.33%
Cambio (1 año)
3,100.00%
País
US
Comercio Invitae Corporation (NVTA)
Categoría
Healthcare
EPS de Invitae Corporation (NVTA)
EPS a fecha de 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de Invitae Corporation, el EPS actual de la empresa (TTM) es 0. Al final del año 2026, la empresa tenía un EPS de 0 igual a al EPS de 2026, que fue de 0.
Historial de EPS de Invitae Corporation desde 2026 hasta 2026
EPS al final de cada año
| Año | EPS | Cambiar |
|---|---|---|
| Not enough data for the provided dates. | ||
EPS de empresas similares o competidoras
| Empresa | EPS | Diferencia de EPS | País |
|---|---|---|---|
| $18.62 | - |
US
|
|
| $5.65 | - |
US
|
|
| $-1.36 | - |
US
|
|
| - | - |
CN
|
|
| $5.09 | - |
US
|
